BlackRock Advisors’s iBio IBIO Stock Holding History

BlackRock Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Hold	4	–	–	﹤0.01%	3589
2016 Q3	$12K	Hold	4	–	–	﹤0.01%	3547
2016 Q2	$15K	Hold	4	–	–	﹤0.01%	3508
2016 Q1	$12K	Hold	4	–	–	﹤0.01%	3544
2015 Q4	$12K	Hold	4	–	–	﹤0.01%	3596
2015 Q3	$14K	Buy	4 +2	+100%	+$7.42K	﹤0.01%	3591
2015 Q2	$11K	Buy	+2	New	+$9.3K	﹤0.01%	3601

Other funds holding IBIO

ACP

Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

ACP

Aveo Capital Partners Englewood, Colorado $601M AUM 5.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BlackRock Advisors's IBIO Position: Q4 2016 in Review

BlackRock Advisors held its iBio (IBIO) position steady in Q4 2016 at 4 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #3589.

BlackRock Advisors first reported a position in IBIO in Q2 2015 and has held it in 7 quarters since. The position peaked at $15K in Q2 2016. 17 funds tracked by Wall St. Rank hold IBIO as of Q4 2016.

BlackRock Advisors held 4 shares of iBio worth $8K as of Q4 2016.
BlackRock Advisors left its iBio share count unchanged in Q4 2016.
iBio made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3589 holding.
BlackRock Advisors first reported a position in iBio in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's iBio position peaked at $15K in Q2 2016.
17 funds tracked by Wall St. Rank held iBio as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.